Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities
暂无分享,去创建一个
[1] J. Schneider,et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease , 2002, Annals of neurology.
[2] T. Robbins,et al. Central cholinergic systems and cognition. , 1997, Annual review of psychology.
[3] A. Cuello,et al. Age-related variations in plasticity of rat basal forebrain cholinergic neurons after cortical lesions , 1988, Brain Research.
[4] E. Masliah,et al. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease , 2000, Neurology.
[5] L. Thal,et al. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients , 2000, Neurobiology of Aging.
[6] Matcheri S. Keshavan,et al. Toward a Neurodevelopmental Model of Obsessive–Compulsive Disorder , 1998, Biological Psychiatry.
[7] M. Sarter,et al. Sustained Visual Attention Performance-Associated Prefrontal Neuronal Activity: Evidence for Cholinergic Modulation , 2000, The Journal of Neuroscience.
[8] E. Tani,et al. Cytotoxic Fragment of Amyloid Precursor Protein Accumulates in Hippocampus after Global Forebrain Ischemia , 1996, Journal of Cerebral Blood Flow and Metabolism.
[9] J. Blusztajn,et al. Choline, a Vital Amine , 1998, Science.
[10] J. Buccafusco,et al. The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development , 2003, Journal of Pharmacology and Experimental Therapeutics.
[11] C. Geula,et al. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. , 1996, Cerebral cortex.
[12] Steffen Roßner,et al. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling , 1998, Progress in Neurobiology.
[13] M. Crossley,et al. Age-related differences in concurrent-task performance of normal adults: evidence for a decline in processing resources. , 1992, Psychology and aging.
[14] J. Turchi,et al. Age- and Dementia-Associated Impairments in Divided Attention: Psychological Constructs, Animal Models, and Underlying Neuronal Mechanisms , 2001, Dementia and Geriatric Cognitive Disorders.
[15] T. Hortobágyi,et al. Functional Recovery of Cholinergic Basal Forebrain Neurons under Disease Conditions: Old Problems, New Solutions? , 2002, Reviews in the neurosciences.
[16] T. Crook,et al. Diagnosis, assessment and treatment of age-associated memory impairment. , 1991, Journal of neural transmission. Supplementum.
[17] J. Hodges,et al. Attention and executive deficits in Alzheimer's disease. A critical review. , 1999, Brain : a journal of neurology.
[18] P. Luiten,et al. Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.
[19] T. Deacon,et al. Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system , 1998, Neuroreport.
[20] F. Kagitani,et al. Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats , 2000, Neuroscience Letters.
[21] Raja Parasuraman,et al. Alzheimer disease constricts the dynamic range of spatial attention in visual search , 2000, Neuropsychologia.
[22] R. Cowburn,et al. Receptor‐Effector Coupling Dysfunctions in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[23] N. Lavine,et al. Reduction in p140-TrkA Receptor Protein within the Nucleus Basalis and Cortex in Alzheimer's Disease , 1997, Experimental Neurology.
[24] L S Honig,et al. Aging and Alzheimer's disease: lessons from the Nun Study. , 1998, The Gerontologist.
[25] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[26] E. Hamel,et al. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] Roberta F. White,et al. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.
[28] M. Sofroniew,et al. Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.
[29] R. Kalaria. Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations , 2002, Cerebrovascular Diseases.
[30] C. Iadecola,et al. Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.
[31] A. Björklund,et al. Experimental studies on the induction and prevention of retrograde degeneration of basal forebrain cholinergic neurons. , 1986, Progress in brain research.
[32] L. Descarries,et al. Ultrastructural features of the acetylcholine innervation in the developing parietal cortex of rat , 2002, The Journal of comparative neurology.
[33] H. Phillips,et al. Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits , 1997 .
[34] Edward J. Golob,et al. Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[35] J. Haxby,et al. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Butcher,et al. Postnatal development of cholinergic neurons in the rat: I. Forebrain , 1991, Brain Research Bulletin.
[37] G. Sedvall,et al. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP , 2001, European Journal of Nuclear Medicine.
[38] R. Quirion,et al. β-Amyloid peptides as direct cholinergic neuromodulators: a missing link? , 1998, Trends in Neurosciences.
[39] E. Cochran,et al. Down‐regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease , 2001, The Journal of comparative neurology.
[40] S. Leurgans,et al. Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.
[41] Arthur D. Fisk,et al. Aging and Skilled Performance : Advances in Theory and Applications , 1996 .
[42] A. D. Smith,et al. Effects of age and a divided attention task presented during encoding and retrieval on memory. , 1989, Journal of experimental psychology. Learning, memory, and cognition.
[43] T. Harkany,et al. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca2+ antagonist nimodipine , 2000, Neuroscience.
[44] D. Butterfield,et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.
[45] F. Craik,et al. Effects of aging and task difficulty on divided attention performance. , 1988, Journal of experimental psychology. Human perception and performance.
[46] Sudha Seshadri,et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .
[47] T. Nabeshima,et al. Amyloid β-peptide induces cholinergic dysfunction and cognitive deficits: a minireview , 2002, Peptides.
[48] L. Descarries,et al. The cholinergic innervation develops early and rapidly in the rat cerebral cortex: a quantitative immunocytochemical study , 2001, Neuroscience.
[49] R. Quirion,et al. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. , 2002, Progress in neurobiology.
[50] A. Granholm,et al. Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome , 2000, Experimental Neurology.
[51] S. Wisniewski,et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.
[52] D. Surmon,et al. Longitudinal diagnosis of memory disorders. , 1992, Age and ageing.
[53] Laura Fratiglioni,et al. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment , 2003, Acta neurologica Scandinavica. Supplementum.
[54] T. Slotkin,et al. Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. , 2002, Environmental health perspectives.
[55] A. Nuñez,et al. Electrophysiological evidence for the existence of a posterior cortical–prefrontal–basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas , 2003, Neuroscience.
[56] D. Hogan,et al. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. , 1995, Archives of neurology.
[57] P. S. St George-Hyslop,et al. Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.
[58] E. Tangalos,et al. Mild cognitive impairment in the oldest old , 2003, Neurology.
[59] M. Hayashi,et al. Changes in BDNF-immunoreactive structures in the hippocampal formation of the aged macaque monkey , 2001, Brain Research.
[60] M. Frotscher,et al. Complete Deletion of the Neurotrophin Receptor p75NTRLeads to Long-Lasting Increases in the Number of Basal Forebrain Cholinergic Neurons , 2002, The Journal of Neuroscience.
[61] D. Bredesen,et al. p75NTR and apoptosis: Trk-dependent and Trk-independent effects , 1997, Trends in Neurosciences.
[62] L. Nyberg,et al. Effects of division of attention during encoding and retrieval on age differences in episodic memory. , 1997, Experimental aging research.
[63] J. Hodges,et al. Relationship between functional and neuropsychological performance in early Alzheimer disease. , 2000, Alzheimer disease and associated disorders.
[64] C. Lyketsos,et al. Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. , 1999, The American journal of psychiatry.
[65] J. Growdon,et al. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.
[66] C. Masters,et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.
[67] A. Baddeley,et al. Autobiographical memory and executive function in early dementia of Alzheimer type , 1995, Neuropsychologia.
[68] W. Mcentee,et al. Age-associated memory impairment , 1995, Neurology.
[69] L. Giambra,et al. Sustained attention and aging: overcoming the decrement? , 1997, Experimental aging research.
[70] M. Sarter,et al. Increases in cortical acetylcholine release during sustained attention performance in rats. , 2000, Brain research. Cognitive brain research.
[71] P. Holland,et al. Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[72] M. Nissen,et al. Attentional requirements of learning: Evidence from performance measures , 1987, Cognitive Psychology.
[73] S. Ferris,et al. Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .
[74] C. Hohmann. A morphogenetic role for acetylcholine in mouse cerebral neocortex , 2003, Neuroscience & Biobehavioral Reviews.
[75] L. Thal,et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.
[76] S. Gauthier,et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[77] J. Wess,et al. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[78] M. Stryker,et al. Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development , 2001, Neuroscience.
[79] J. Yakel,et al. β-Amyloid1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice , 2001, The Journal of Neuroscience.
[80] R. Quirion,et al. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. , 1998, Journal of neurochemistry.
[81] J. Haxby,et al. Attentional costs of mental operations in young and old adults , 1989 .
[82] J. Morris. Challenging assumptions about Alzheimer's disease: Mild cognitive impairment and the cholinergic hypothesis , 2002, Annals of neurology.
[83] D A Bennett,et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease , 1999, The Journal of comparative neurology.
[84] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[85] M. Sarter,et al. Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG‐saporin‐induced lesions on olfactory span performance , 2000, The European journal of neuroscience.
[86] R. Hellweg,et al. Insights Into the Role of the Cholinergic Component of the Septohippocampal Pathway: What Have We Learned from Experimental Lesion Studies? , 1997, Brain Research Bulletin.
[87] L. Ricceri,et al. Early neonatal 192 IgG saporin induces learning impairments and disrupts cortical morphogenesis in rats , 2002, Brain Research.
[88] B. Kramer,et al. p75 nerve growth factor receptor is important for retrograde transport of neurotrophins in adult cholinergic basal forebrain neurons , 1999, Neuroscience.
[89] Anthony R. McIntosh,et al. The Effects of Divided Attention on Encoding- and Retrieval-Related Brain Activity: A PET Study of Younger and Older Adults , 2000, Journal of Cognitive Neuroscience.
[90] R. Nebes,et al. Focused and Divided Attention in Alzheimer's Disease , 1989, Cortex.
[91] Fergus I. M. Craik,et al. Aging and Cognitive Deficits , 1982 .
[92] N Butters,et al. Directed and divided attention in Alzheimer's disease: impairment in shifting of attention to global and local stimuli. , 1992, Journal of clinical and experimental neuropsychology.
[93] G. Small. The role of neuroimaging in the diagnosis of vascular dementia , 2002, Acta neurologica Scandinavica. Supplementum.
[94] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[95] N. Muzyczka,et al. NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats , 2000, Brain Research.
[96] T. Beach,et al. The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease , 2000, Journal of neuropathology and experimental neurology.
[97] P. Dijkhuizen,et al. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease , 1996, Neuroscience.
[98] M. O'Neal,et al. Role of nucleus basalis in cholinergic control of cortical blood flow , 1991, Journal of neuroscience research.
[99] D. Salat,et al. Intraseptal injection of the cholinergic immunotoxin 192-IgG saporin fails to disrupt latent inhibition in a conditioned taste aversion paradigm , 1996, Brain Research.
[100] ML Voytko,et al. Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995 Mar;15(3): following table of contents] , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[101] M. Sarter,et al. Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable , 1998, Brain Research Reviews.
[102] M. Sarter,et al. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents , 1999, Neuroscience.
[103] M. Gallagher,et al. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. , 1995, Behavioral neuroscience.
[104] J. Brandt,et al. Intelligence and education as predictors of cognitive state in late life , 1995, Neurology.
[105] L O'Hanlon,et al. Age Differences in Implicit and Explicit Associative Memory: Exploring Elaborative Processing Effects , 2001, Experimental aging research.
[106] K. Kawashima,et al. Nicotine-induced NO-mediated increase in cortical cerebral blood flow is blocked by β2-adrenoceptor antagonists in the anesthetized rats , 2002, Autonomic Neuroscience.
[107] J. Cerella,et al. Aging and dual-task performance: a meta-analysis. , 2003, Psychology and aging.
[108] T. Robbins,et al. Distinct Changes in Cortical Acetylcholine and Noradrenaline Efflux during Contingent and Noncontingent Performance of a Visual Attentional Task , 2001, The Journal of Neuroscience.
[109] L. Maffei,et al. Expression of the Nerve Growth Factor Receptors Trka and P75 Ntr in the Visual Cortex of the Rat: Development and Regulation by the Cholinergic Input , 2022 .
[110] S. Leurgans,et al. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. , 2003, Archives of neurology.
[111] E. Mackenzie,et al. Cortical blood flow increases induced by stimulation of the substancia innominata in the unanesthetized rat , 1989, Brain Research.
[112] Vladimir V. Frolkis,et al. Neurobiology of Aging , 2019, Psychobiology of Behaviour.
[113] C. Duyckaerts,et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy , 2003, Neurobiology of Aging.
[114] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[115] M. King,et al. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain , 1999, Neuroscience.
[116] M. Sofroniew,et al. Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated trka expression in the medial septum of aged rats , 1994, Neuroscience.
[117] T. Crook,et al. Age-associated memory impairment: diagnostic criteria and treatment strategies. , 1987, International journal of neurology.
[118] R. Quirion,et al. Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.
[119] O. Isacson,et al. Cortico‐hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice , 2002, The European journal of neuroscience.
[120] W H Brouwer,et al. Divided Attention in Experienced Young and Older Drivers: Lane Tracking and Visual Analysis in a Dynamic Driving Simulator , 1991, Human factors.
[121] A. Fagan,et al. A Role for TrkA during Maturation of Striatal and Basal Forebrain Cholinergic Neurons In Vivo , 1997, The Journal of Neuroscience.
[122] S. Arneric,et al. Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[123] L. Thal,et al. The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease , 2000, Neurology.
[124] David A Lewis,et al. Schizophrenia as a disorder of neurodevelopment. , 2002, Annual review of neuroscience.
[125] D R Wekstein,et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.
[126] N. Berardi,et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .
[127] J. Hodges,et al. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer’s disease: relationship to episodic and semantic memory impairment , 2000, Neuropsychologia.
[128] F. Kagitani,et al. Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex. , 2002, The Japanese journal of physiology.
[129] J. Sullivan,et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. , 1994, The Journal of pharmacology and experimental therapeutics.
[130] J. Thornby,et al. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging , 2002, Journal of the Neurological Sciences.
[131] R. Kalaria. Similarities between Alzheimer's disease and vascular dementia , 2002, Journal of the Neurological Sciences.
[132] J. Morris,et al. Evidence That Age-Associated Memory Impairment Is Not a Normal Variant of Aging , 2001, Alzheimer disease and associated disorders.
[133] F. Pirozzolo,et al. Brain choline acetyltransferase and mental function in Alzheimer disease. , 1999, Archives of neurology.
[134] J. Haxby,et al. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. , 2000, Science.
[135] Raja Parasuraman,et al. Divided attention and metabolic brain dysfunction in mild dementia of the Alzheimer's type , 1991, Neuropsychologia.
[136] S. Scott,et al. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. , 1996, Brain research. Molecular brain research.
[137] Karen Thompson,et al. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model , 1992, Brain Research Reviews.
[138] L. Nilsson. Memory function in normal aging , 2003, Acta neurologica Scandinavica. Supplementum.
[139] D. Price,et al. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates , 1991, Annals of neurology.
[140] M. Baxter,et al. Cholinergic and noncholinergic septal neurons modulate strategy selection in spatial learning , 2001, The European journal of neuroscience.
[141] E. Perry,et al. Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.
[142] R. Schliebs,et al. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein , 2002, Brain Research.
[143] O. Inanami,et al. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats , 1989, Neuroscience Letters.
[144] T. Mitzner,et al. Language decline across the life span: findings from the Nun Study. , 2001, Psychology and aging.
[145] S. Arneric,et al. Cortical cerebral blood flow governed by the basal forebrain: Age-related Impairments , 1991, Neurobiology of Aging.
[146] M. Nader,et al. Imaging of cholinergic terminals using the radiotracer [18F](+)‐4‐fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates , 1997, Synapse.
[147] S. L. Mobley,et al. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[148] R Parasuraman,et al. Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[149] B. Reisberg,et al. Mild cognitive impairment in the elderly , 1991, Neurology.
[150] D. Holtzman,et al. Nerve growth factor and the neurotrophic factor hypothesis , 1996, Brain and Development.
[151] G. J. Crystal,et al. Regional blood flow in canine brain during nicotine infusion: effect of autonomic blocking drugs. , 1983, Stroke.
[152] R Parasuraman,et al. Skill development in vigilance: effects of event rate and age. , 1991, Psychology and aging.
[153] P. Luiten,et al. Cortical projection patterns of magnocellular basal nucleus subdivisions as revealed by anterogradely transportedPhaseolus vulgaris leucoagglutinin , 1987, Brain Research.
[154] E. Mufson,et al. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate , 1996, Brain Research.
[155] R. Quirion,et al. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[156] X. Tong,et al. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease , 1999, Neuroscience.
[157] M. Sarter,et al. Interactions between aging and cortical cholinergic deafferentation on attention☆ , 2002, Neurobiology of Aging.
[158] K. Davis,et al. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[159] E. Cochran,et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease , 2000, The Journal of comparative neurology.
[160] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[161] Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory. , 1996, Behavioral neuroscience.
[162] K Ball,et al. Visual attention impairments in Alzheimer’s disease , 2000, Neurology.
[163] M. Sarter,et al. Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention , 2002, Neuroscience.
[164] G. Baylis,et al. The Role of Attention in a Spatial Memory Task in Alzheimer Disease Patients , 1997, Alzheimer Disease and Associated Disorders.
[165] E. Tangalos,et al. Memory function in normal aging , 1992, Neurology.
[166] Changiz Geula,et al. Abnormalities of neural circuitry in Alzheimer's disease , 1998, Neurology.
[167] A. Baddeley,et al. Attentional control in Alzheimer's disease. , 2001, Brain : a journal of neurology.
[168] J. C. Torre,et al. Evidence that Alzheimer’s disease is a microvascular disorder: the role of constitutive nitric oxide , 2000, Brain Research Reviews.
[169] G. Wörtwein,et al. Cholinergic Control of Nerve Growth Factor in Adult Rats: Evidence from Cortical Cholinergic Deafferentation and Chronic Drug Treatment , 1997, Journal of neurochemistry.
[170] M. Sarter,et al. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis , 1997, Brain Research Reviews.
[171] Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders , 1999 .
[172] O. Inanami,et al. Responses of regional cerebral blood flow following focal electrical stimulation of the nucleus basalis of Meynert and the medial septum using the [14C]iodoantipyrine method in rats , 1990, Neuroscience Letters.
[173] J. Lauterborn,et al. Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons. , 1998, Cerebral cortex.
[174] R. Bucks,et al. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful , 2003, Journal of neurology, neurosurgery, and psychiatry.
[175] P. Grammas,et al. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. , 2002, The American journal of pathology.
[176] R. Quirion,et al. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain , 1996, The Journal of comparative neurology.
[177] J. Haxby,et al. Attention and brain function in Alzheimer's disease: A review. , 1993 .
[178] W. Meck,et al. Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. , 1989, Behavioral neuroscience.
[179] T. Beach,et al. Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine , 2001, Neuroscience Letters.
[180] T. Beach,et al. Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition , 2000, Neuroscience Letters.
[181] M. Sarter,et al. Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory? , 2003, Neurobiology of Learning and Memory.
[182] C. Geula,et al. Loss of calbindin‐D28k from aging human cholinergic basal forebrain: Relation to neuronal loss , 2003, The Journal of comparative neurology.
[183] Patrik Vuilleumier,et al. Effects of attention and emotion on repetition priming and their modulation by cholinergic enhancement. , 2003, Journal of neurophysiology.
[184] M. Decker,et al. Effects of intraseptal injection of 192-IgG-saporin in mature and aged Long-Evans rats , 1996, Brain Research.
[185] John R Hodges,et al. Dissociation between top‐down attentional control and the time course of visual attention as measured by attentional dwell time in patients with mild cognitive impairment , 2003, The European journal of neuroscience.
[186] J. Price,et al. Absence of cognitive impairment or decline in preclinical Alzheimer’s disease , 2001, Neurology.
[187] P. Luiten,et al. Ultrastructural localization of cholinergic muscarinic receptors in rat brain cortical capillaries , 1996, Brain Research.
[188] M. Sarter,et al. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. , 1996, Behavioral neuroscience.
[189] M. Sofroniew,et al. Increased vulnerability of septal cholinergic neurons to partial loss of target neurons in aged rats , 1996, Neuroscience.
[190] G. Sedvall,et al. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease , 2000, Psychopharmacology.
[191] R. Neve,et al. Alzheimer’s disease: a dysfunction of the amyloid precursor protein 1 1 Published on the World Wide Web on 11 September 2000. , 2000, Brain Research.
[192] R. Bartus,et al. On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis , 2000, Experimental Neurology.
[193] L. Harrell,et al. Cholinergic activity and amyloid precursor protein metabolism , 1997, Brain Research Reviews.
[194] A. Granholm,et al. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh , 2002, Trends in Neurosciences.
[195] E. Mufson,et al. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases , 1999, Progress in Neurobiology.
[196] T. Robbins,et al. Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type , 1990, Neuropsychologia.
[197] J. Price,et al. Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.
[198] W. A. Wilson,et al. Prenatal Choline Supplementation Protects against Postnatal Neurotoxicity , 2002, The Journal of Neuroscience.
[199] M. Sarter,et al. Microsphere embolism‐induced cortical cholinergic deafferentation and impairments in attentional performance , 2005, The European journal of neuroscience.
[200] M. Sarter,et al. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. , 1997, Brain research. Cognitive brain research.
[201] L. Wilkinson,et al. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system , 1994, Neuroscience.
[202] S. Takeo,et al. Failure in learning task and loss of cortical cholinergic fibers in microsphere-embolized rats , 1997, Experimental Brain Research.
[203] F. Craik,et al. The attentional demands of encoding and retrieval in younger and older adults: 1. Evidence from divided attention costs. , 1998, Psychology and aging.
[204] U. Ueberham,et al. In Vivo Regulation of Amyloid Precursor Protein Secretion in Rat Neocortex by Cholinergic Activity , 1997, European Journal of Neuroscience.
[205] Lars Bäckman,et al. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. , 2002, The American journal of psychiatry.
[206] D. Donnelly-roberts,et al. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. , 1994, The Journal of pharmacology and experimental therapeutics.
[207] B. Sahakian,et al. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB , 2005, Psychopharmacology.
[208] James A. Mortimer,et al. Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .
[209] Raja Parasuraman,et al. Genetics and visual attention: Selective deficits in healthy adult carriers of the ɛ4 allele of the apolipoprotein E gene , 2000 .
[210] O. Scremin,et al. Selective immunotoxin-induced cholinergic deafferentation alters blood flow distribution in the cerebral cortex , 1999, Brain Research.
[211] R. Quirion,et al. Amyloid β‐Peptide Inhibits High‐Affinity Choline Uptake and Acetylcholine Release in Rat Hippocampal Slices , 1998 .
[212] Y. Li,et al. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[213] E. Hamel,et al. Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex , 1997, Neuroscience.
[214] M. Sarter,et al. The cognitive neuroscience of sustained attention: where top-down meets bottom-up , 2001, Brain Research Reviews.
[215] Jennifer A. Mangels,et al. Memory and Cognitive Abilities in University Professors: Evidence for Successful Aging , 1995 .
[216] R. Parasuraman,et al. Sensory and Cognitive Vigilance: Effects of Age on Performance and Subjective Workload , 1993 .
[217] J V Haxby,et al. Visuospatial attention in dementia of the Alzheimer type. , 1992, Brain : a journal of neurology.
[218] E. Pioro,et al. Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert , 1994, Brain Research.
[219] D Wyper,et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[220] P. Grammas,et al. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.
[221] D. K. Berg,et al. β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.